Over 101,000 Americans need a kidney transplant, but only 17,000 people receive one each year due to a donated organ shortage. Credit: Zach Bundy, WFYI This article is part of The State of Science, a ...

National coverage analysis is the first-of-its kind for a minimally invasive, interventional treatment for high blood pressure Milestone is supported by large public health need and robust, long-term ...

Analysts are optimistic about Medtronic (MDT) after the Centers for Medicare and Medicaid Services (CMS) proposed to cover renal denervation for uncontrolled hypertension. CMS on Thursday posted its ...

Medtronic and Recor Medical may have some fresh resolutions for the new year after the Centers for Medicare & Medicaid Services (CMS) recently approved reimbursements for the two companies’ respective ...

Medtronic reported that it has begun testing an expansion of its renal denervation approach for dropping stubbornly high blood pressure, by also treating vessels outside of the kidneys. The company ...

Medtronic was successful in winning a nod from FDA for the Symplicity Spyral, a renal denervation technology, but that’s only half the battle. Now the Dublin-based company has to contend with adoption ...